.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
UBS
Boehringer Ingelheim
Federal Trade Commission
Chinese Patent Office
McKinsey
Daiichi Sankyo
Teva
Dow
Merck

Generated: July 25, 2017

DrugPatentWatch Database Preview

SULFACETAMIDE SODIUM Drug Profile

« Back to Dashboard

Which patents cover Sulfacetamide Sodium, and when can generic versions of Sulfacetamide Sodium launch?

Sulfacetamide Sodium is a drug marketed by Fougera Pharms, Akorn, Perrigo Co Tennessee, Pharmafair, Sandoz Inc, Bausch And Lomb, Taro, and Alcon Pharms Ltd. and is included in twelve NDAs.

The generic ingredient in SULFACETAMIDE SODIUM is prednisolone sodium phosphate; sulfacetamide sodium. There are eighty-six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the prednisolone sodium phosphate; sulfacetamide sodium profile page.

Summary for Tradename: SULFACETAMIDE SODIUM

Patents:0
Applicants:8
NDAs:12
Suppliers / Packagers: see list17
Bulk Api Vendors: see list136
Clinical Trials: see list2,361
Patent Applications: see list3,189
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:SULFACETAMIDE SODIUM at DailyMed

Pharmacology for Tradename: SULFACETAMIDE SODIUM

Ingredient-typeSulfonamides
Drug ClassSulfonamide Antibacterial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms
SULFACETAMIDE SODIUM
sulfacetamide sodium
LOTION;TOPICAL077015-001Nov 17, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Sandoz Inc
SULFACETAMIDE SODIUM
sulfacetamide sodium
SOLUTION/DROPS;OPHTHALMIC089560-001Oct 18, 1988ATRXNoNo► Subscribe► Subscribe► Subscribe
Perrigo Co Tennessee
SULFACETAMIDE SODIUM
sulfacetamide sodium
OINTMENT;OPHTHALMIC080029-001Approved Prior to Jan 1, 1982RXNoYes► Subscribe► Subscribe► Subscribe
Bausch And Lomb
SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE
prednisolone sodium phosphate; sulfacetamide sodium
SOLUTION/DROPS;OPHTHALMIC074449-001Dec 29, 1995ATRXNoYes► Subscribe► Subscribe► Subscribe
Bausch And Lomb
SULFACETAMIDE SODIUM
sulfacetamide sodium
SOLUTION/DROPS;OPHTHALMIC040066-001Dec 28, 1994ATRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Chubb
Novartis
Medtronic
Mallinckrodt
Johnson and Johnson
UBS
QuintilesIMS
Julphar
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot